Aflibercept in Wet AMD Beyond the First Year of Treatment
Aflibercept in Wet AMD Beyond the First Year of Treatment
It should be noted that, when referring to the label, the authors refer to month- rather than week-based dosing in this paper to reflect the licensed posology for aflibercept (stated in months). However, as most clinics are set up using weekly rather than monthly schedules, practice recommendations are given using week- rather than month-based dosing. As an example, '8-weekly' dosing is considered to be equivalent to '2-monthly' dosing. The dosing schedule for aflibercept in Year 1 is shown in Figure 3.
(Enlarge Image)
Figure 3.
Dosing schedule for aflibercept in Year 1. *Indicates when the treatment approach for post-Year 1 is determined ie at the time of the seventh injection in Year 1.
Recommendations for Aflibercept After Year 1
It should be noted that, when referring to the label, the authors refer to month- rather than week-based dosing in this paper to reflect the licensed posology for aflibercept (stated in months). However, as most clinics are set up using weekly rather than monthly schedules, practice recommendations are given using week- rather than month-based dosing. As an example, '8-weekly' dosing is considered to be equivalent to '2-monthly' dosing. The dosing schedule for aflibercept in Year 1 is shown in Figure 3.
(Enlarge Image)
Figure 3.
Dosing schedule for aflibercept in Year 1. *Indicates when the treatment approach for post-Year 1 is determined ie at the time of the seventh injection in Year 1.